Musk confirms SpaceX IPO plans for 2026

Elon Musk confirms that SpaceX plans to go public in 2026.

That's why I'm looking into ways to own a stake before it officially trades on the NASDAQ.

Click here to get my urgent report (email required).

Elon Musk now believes Space Exploration Technologies must raise $30 billion to fund his new Space Master Plan.

SpaceX is looking at going public with a $1.5 trillion valuation - making this the biggest IPO ever.

Here's how to claim a stake before the IPO.

Ian Wyatt

*By clicking the link above you'll receive emails from IPO Watch and Ian Wyatt.

 


 
 
 
 
 
 

Special Report

3 Rebound Candidates With Technical Tailwinds

Authored by Dan Schmidt. First Published: 3/13/2026.

Computer monitor displaying a stock chart shifting from a steep red decline to a bright green upward trend, illustrating a technical market rebound.

Key Points

  • Volatile markets are often good times for risk seekers to look for momentum reversals to score outsized profits.
  • To trade on short-term signals, technical analysis is a necessary concept to understand for your research.
  • According to technical indicators such as the RSI and MACD, these three stocks have potential to rebound in 2026.
  • Special Report: Elon Musk: This Could Turn $100 into $100,000

When volatility reigns, many investors seek shelter in low-beta sectors and dividend-paying stocks. But volatility also creates opportunities for those who can stomach the swings, which is why risk seekers often turn to technical analysis. Fundamentals are the primary driver of long-term stock performance, but technical indicators can help pinpoint when trends flip, enabling day and swing traders to capture profits from short-term movements. Here are three stocks hiding in the volatility that could be on the verge of a major trend reversal.

Using Technical Indicators Like MACD and RSI to Identify Momentum Shifts

March has certainly been a volatile month, and with the ongoing conflict involving Iran, this environment is likely to persist through April. Technical analysis becomes especially useful when markets are gyrating and momentum swings like a pendulum. Let's review the mechanics of two crucial momentum oscillators before moving on to the stock picks:

  • Moving Average Convergence Divergence (MACD) Indicator - Uses two exponential moving averages (EMAs) to measure momentum and identify trend shifts. The 12-day EMA is compared to the 26-day EMA, and the difference is plotted as the MACD line; a 9-day EMA of that difference serves as the signal line. When the MACD line crosses above the signal line, it's a signal that bullish momentum may be building.
  • Relative Strength Index (RSI) - Measures the magnitude of recent price changes using 14 days of average gains and average losses. The RSI is useful for identifying overbought and oversold stocks on a 0–100 scale. If the RSI rises above 70, the stock is considered overbought, suggesting upward momentum may be nearing exhaustion. Likewise, an RSI below 30 is oversold, indicating a potential bullish trend reversal.

3 Stocks With Technicals Pointing to a Trend Reversal

The Biggest IPO Ever: Claim Your Stake Today (Ad)

What if you could shrink your entire wealth journey from decades down to just 24 hours?

Sounds impossible…

But I'll show you how Elon Musk is about to make it a reality.

This could be the best investment opportunity of the decade.tc pixel

Using the MACD and RSI, we've identified three beaten-up stocks that could be poised to reverse. Keep in mind that technical trading is time-consuming and risky; only experienced investors should pursue day- and swing-trading strategies.

Wayfair: Tariff and Trend Relief Could Mark the Bottom

The retail sector was hit hard by tariffs, especially companies that depend on low-cost imports such as Wayfair Inc. (NYSE: W). Furniture imports were a focal point of the Trump administration's IEPPA tariffs, but those measures have now been struck down, and companies like Wayfair can apply for relief.

W stock chart displaying a convergence of technical indicators like a double bottom and oversold RSI.

The tariff decision may have been a classic "buy the rumor, sell the news" event, since many investors expected the tariffs wouldn't hold up in court. Now that the fundamental picture is improving, the stock could have finally found a bottom after a lengthy decline. A bullish MACD cross points to improving buying momentum, and the RSI is trending up again after spending about a month in oversold territory.

Lyft: Floor Could Be In for Beleaguered Rideshare Company

Lyft Inc. (NASDAQ: LYFT) will likely remain the Robin to Uber Technologies Inc. (NYSE: UBER)'s Batman, but the market is big enough for both players. LYFT shares are down more than 30% so far this year, wiping out gains since last August and putting the stock roughly back where it was a year ago. The roughly $13 level, however, has proven sticky for buyers and could represent a floor where bullish momentum begins to build. Analysts still carry an average price target of $19.63, implying more than 50% upside from current levels.

LYFT stock chart displaying a recovering RSI and a triple bottom.

Technical setups on the MACD and RSI support a triple-bottom thesis. A bullish MACD crossover highlights the potential reversal, and the RSI is beginning to bounce off the oversold threshold — a move it made in August before the stock rallied roughly 80% over three months.

Caesars Entertainment: Technical Signals Hinted at Potential Catalyst

Shares of Caesars Entertainment Corp. (NASDAQ: CZR) shifted markedly when reports surfaced that Golden Nugget owner Tillman Fertitta was planning a takeover bid. The bid was reportedly for $7 billion, which would value the company at about $34 per share — a significant premium to the roughly $28 trading level at the time. Caesars is currently one of the largest Las Vegas operators, with a market cap near $5.8 billion and a portfolio that includes Caesars Palace, Planet Hollywood, Harrah's and The Cromwell.

Casino stocks have faced pressure from online sportsbooks such as DraftKings Inc. (NASDAQ: DKNG) and from prediction markets like Kalshi and PolyMarket, which are now available through brokers such as Webull and Robinhood Markets Inc. (NASDAQ: HOOD). Despite that competition, Caesars reported $2.9 billion in revenue in Q4 2025, a 4.2% year-over-year gain that topped expectations. The takeover chatter has also triggered speculation about spinning off the digital-gaming business, which has seen record revenue growth and could unlock capital for debt reduction.

CZR stock chart displaying a breakout underway.

News of Fertitta's bid surfaced on March 11, but rumors had apparently circulated beforehand; the stock is up more than 55% over the past month. CZR has been a capital sink over the last five years, losing more than 70% of its value, so this breakout is a welcome change for investors. Multiple technical indicators point to a bullish trend reversal, including crosses above both the 50-day and 200-day moving averages and a bullish MACD crossover. The MACD histogram also suggests upside momentum remains strong, so this rally could still be in its early innings.


Just For You

Members of Congress Bought These 5 Stocks—Should You?

Written by Chris Markoch. Date Posted: 3/18/2026.

Close-up of a glowing Broadcom-style semiconductor chip mounted on a circuit board inside a modern data center, symbolizing the AI chip industry.

Key Points

  • Congressional disclosures highlighted five stocks recently traded by lawmakers, including BigBear.ai, Eli Lilly, and Broadcom.
  • AI, defense, semiconductors, and GLP-1 healthcare trends appear across several trades, pointing to sectors with strong growth narratives.
  • While disclosures lag by up to 45 days, tracking congressional trades can provide useful watchlist ideas for individual investors.
  • Special Report: Elon Musk: This Could Turn $100 into $100,000

Lawmakers on both sides of the aisle have recently proposed banning members of Congress from trading individual stocks while in office. This debate dates back to the STOCK Act of 2012, which was intended as a fix: the law requires politicians to publicly disclose trades within 45 days of the transaction.

Critics have long argued that disclosure alone doesn't go far enough. More recent proposals, including the ETHICS Act and the TRUST in Congress Act, would prohibit active stock trading by members altogether.

The Biggest IPO Ever: Claim Your Stake Today (Ad)

What if you could shrink your entire wealth journey from decades down to just 24 hours?

Sounds impossible…

But I'll show you how Elon Musk is about to make it a reality.

This could be the best investment opportunity of the decade.tc pixel

Congress moves slowly, so until—and unless—those acts become law, the 45-day disclosure window remains one of the few tools everyday investors have to see where elected officials are putting their own money. A scan of the most recent 90 days of filings identified five stocks worth watching, ranging from a small-cap AI defense play to a large-cap semiconductor giant at the center of the artificial intelligence infrastructure boom.

BigBear.ai: A Small-Cap AI Defense Play Getting Repeat Attention

Representative Lisa McClain of Michigan made two separate purchases of BigBear.ai (NYSE: BBAI) in February, first on Feb. 4 and again on Feb. 6.

Combined, the purchases were valued between $16,000 and $65,000.

BigBear.ai is a small-cap decision-intelligence company that derives a significant portion of its revenue from U.S. government contracts in defense and national security. McClain is not a first-time buyer: in August 2024 she reportedly became the first politician to disclose owning BBAI stock. Her return to the name suggests this is more than a one-off.

Her seat on the Financial Services Subcommittee on National Security is relevant context to keep in mind.

Cracker Barrel: A Quick Trade From a Top Congressional Performer

Representative Tim Moore of North Carolina was named the top-performing member of Congress for stock trades in 2025, with a reported 52% gain.

He was active in Cracker Barrel (NASDAQ: CBRL) around the new year. Moore purchased CBRL stock on Dec. 31, then sold a larger position just days later on Jan. 5, appearing to lock in a quick profit on a beaten-down restaurant stock.

The buy was in the $15,000–$50,000 range; the sale was $50,000–$100,000.

It reads more like a tactical short-term trade than a conviction hold, but when a member who outperformed the S&P 500 by a wide margin last year makes a move, even a brief one, it tends to get noticed.

Simply Good Foods: A Double Buy on a Beaten-Down Nutrition Stock

Simply Good Foods (NASDAQ: SMPL) is a more intriguing purchase made by Moore. He made two purchases of Simply Good Foods in February, on Feb. 3 and Feb. 11, each valued between $15,000 and $50,000. According to Quiver Quantitative data, Moore is reportedly the first member of Congress to buy SMPL stock in recent years.

Simply Good Foods, the company behind Atkins and Quest nutrition products, has seen its stock fall roughly 53% over the past year. Moore appears to be buying into weakness with a double purchase in a brand-new position. There is also a macro tailwind argument: as GLP-1 weight-loss drugs push more consumers toward high-protein, low-carb nutrition, consumer staples stocks like Simply Good Foods could benefit from that behavioral shift.

Eli Lilly: GLP-1 Momentum and an Upcoming Obesity Drug Catalyst

Representative David Taylor of Ohio purchased Eli Lilly (NYSE: LLY) stock on Feb. 26; the trade was disclosed on March 6.

That disclosure coincided with Lilly's CFO publicly confirming the company is on track to launch its oral obesity drug, orforglipron, in the second quarter of 2025, pending FDA approval.

Orforglipron has been discussed publicly for months, and the disclosure timeline is standard under the STOCK Act. Still, the sequence of events is the kind of thing that draws attention.

The fundamental case for LLY is substantial: it holds roughly 60% of the U.S. GLP-1 market and has $1.5 billion in pre-launch inventory ready to ship within a week of FDA approval. Additionally, Medicare coverage of the oral pill could begin as early as April at $50 per month for eligible patients.

Broadcom: Multiple Congressional Buys in a Leading AI Chip Stock

Broadcom (NASDAQ: AVGO) stands out because the buying wasn't concentrated in one member—three separate members of Congress purchased AVGO stock in the past 90 days.

Representative Gilbert Ray Cisneros Jr. made purchases in October, November and December. Senator Shelley Moore Capito bought it in early February. And David Taylor, the same Ohio congressman who bought Eli Lilly, picked up Broadcom shares on Jan. 29.

Broadcom reported AI revenue of $12 billion for fiscal year 2025, a 74% year-over-year increase, and guided for $10.7 billion in AI revenue in Q1 2026 alone. The company is also a significant federal government contractor, meaning congressional members may have more than just Wall Street research informing their view of its prospects.

Congressional Trades Are a Clue, Not a Trading Signal

Investors should remember that congressional trade disclosures are a data point, not a trading signal. By the time a disclosure is public, the trade may already be 45 days old and its thesis could be priced in. Correlation between a congressional role and a stock purchase does not imply anything improper.

That said, watching where informed, well-connected investors put their own money—especially when multiple members converge on the same name—is a reasonable part of any investor's research process.

These five stocks may be worth adding to a watchlist, but investors should complete independent research before taking any action.

Thank you for subscribing to TickerReport, where we work around-the-clock
to bring you the latest market-moving news.
 
This email content is a paid sponsorship from Wyatt Investment Research, a third-party advertiser of TickerReport and MarketBeat.
 
Contact Us  |  Unsubscribe
 
© 2006-2026 MarketBeat Media, LLC dba TickerReport. All rights protected.
345 North Reid Place #620, Sioux Falls, SD 57103. U.S.A..

Subscribe to receive free email updates:

0 Response to "Musk confirms SpaceX IPO plans for 2026"

Post a Comment